A 10-year trial involving osteoarthritis and rheumatoid arthritis patients in 13 countries reveals new insights on the cardiovascular safety of widely used nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors, ...
Nov 14, 2016
0
0
(HealthDay)—Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care.
Sep 27, 2016
0
1
(HealthDay)—For subjects at risk of aspirin-associated upper gastrointestinal (UGI) events, long-term PA32540 (enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) appears to be safe, according to a study ...
Mar 15, 2016
0
0
The cardiovascular safety of the obesity treatment naltrexone-bupropion remains uncertain because of the unanticipated early termination of a trial to determine its safety, according to a study appearing in the March 8 issue ...
Mar 8, 2016
0
0
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...
Aug 31, 2015
0
10
Patients with type-2 diabetes and cardiovascular disease can safely take the antihyperglycemic drug sitagliptin without an increased risk of cardiovascular complications - even if they have a history of heart failure - a ...
Aug 31, 2015
0
6
An international, multidisciplinary team including investigators from Brigham and Women's Hospital (BWH) has found that lixisenatide, a member of a class of glucose-lowering drugs frequently prescribed in Europe to patients ...
Jun 8, 2015
0
7
(HealthDay)—Movantik (naloxegol) has been approved by the U.S. Food and Drug Administration to treat opioid-induced constipation, the agency said Tuesday.
Sep 16, 2014
0
0
The oral hormone therapy conjugated equine estrogens (CEEs), which is used by women to relieve menopause symptoms, appears to be associated with increased risk for venous thrombosis (VT, blood clots) and possibly myocardial ...
Sep 30, 2013
0
0
(HealthDay)—The American Medical Association (AMA) has announced the first stage of its improving health outcomes initiative, which aims to optimize the health of the nation with a focus on preventing cardiovascular disease ...
Apr 24, 2013
0
0
